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Objective. Precise identification of various morphotypes of 
Pseduomonas aeruginosa which developed during cystic fibrosis 
(CF) is of prime importance. We aimed to identify the isolates 
of P.  aeruginosa recovered from CF patients at the genus and 
species level through primers targeting oprI and oprL genes via 
PCR.
Methods. Sputum samples or throat swabs were taken from 100 
CF patients and plated on cetrimide agar. All suspected colonies 
were primarily screened for P. aeruginosa by a combination of 
phenotypic tests. Molecular identification of colonies was per-
formed using specific primers for oprI and oprL genes. 
Results. Based on phenotypic tests, P. aeruginosa isolates were 
recovered from 40% of CF patients. Forty isolates yielded ampli-
con of oprI gene using genus-specific primers confirming the 
identity of fluorescent pseudomonads. However, 37 of 40 isolates 
yielded amplicon of oprL gene using species-specific primers, 
verifying the identity of P. aeruginosa. 
Conclusion. This study showed that the species-specific PCR tar-
geting oprL gene can be used as accurate test for identification 
of highly adaptable P. aeruginosa in CF patients. This procedure 
may provide a simple and reliable method for identification of 
various morphotypes. 
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Summary
Introduction
Pseduomonas aeruginosa is considered as the most 
common recovered bacterium from respiratory infec-
tions in cystic fibrosis (CF) patients [1]. Cystic fibrosis 
is a genetic disease caused by mutations in the cystic 
fibrosis transmembrane conductance regulator (CFTR) 
encoding gene. CFTR primarily acts as a chloride ion 
channel and mutation in this gene affects the chloride 
transport and sodium absorption, leading to thickness of 
mucus in lungs [2]. CFTR is also recognized as a cellu-
lar receptor for binding and clearance of P. aeruginosa 
from the lungs [3], therefore malfunction of CFTR may 
lead to persistence of this species and ultimately severe 
pulmonary disease. CF patients are more prone to colo-
nization by a variety of bacteria during their life [4] but 
the majority of CF patients endure P. aeruginosa chron-
ic lung infections [5]. The early colonization of patients 
may occur by susceptible and non-mucoid strains of P. 
aeruginosa, but as early as the colonized bacteria are 
covered by thickened and dehydrated mucosa in lung, 
the bacterial microenvironment will be established. This 
microenvironment creates a way for evasion of bacteria 
and a barrier to antibiotics and consequently selection 
of variants of P. aeruginosa [6]. Despite the prolonged 
antibiotic therapy, P.  aeruginosa is not eradicated in 
such patients and the formation of various morphotypes 
of bacteria during chronic and sustained infection is re-
ported worldwide. The major morphologic alterations of 
P. aeruginosa in CF patients are conversion to mucoid 
variants, loss of pigments, overproduction of alginate, 
formation of small-colony variants, and evolution of 
mutator strains [7-10]. 
The emergence of mucoid variants P. aeruginosa is usu-
ally considered as a poor prognostic indicator in CF pa-
tients  [11]. One of the critical control measures in CF 
patients is accurate species identification. The broad 
phenotypic variation of P. aeruginosa may lead to mis-
indentification of these strains in CF patients. Therefore, 
precise identification of various morphotypes which 
developed during chronic infections and differentiation 
of P. areugionsa from other non-fermentative strains in-
volving in the pathogensis of CF is of prime importance. 
Due to drawbacks of phenotypic methods for identifica-
tion of P. areuginosa morphotypes, we aimed to iden-
tify P. aeruginosa at the genus and species level through 
primers targeting oprI and oprL genes via PCR.
Materials and methods 
In this cross-sectional study, the cases that had a sweat 
chloride equal to or greater than 60 mmol/L and were di-
agnosed as CF patients were included. The patients who 
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treated with antibiotics within the previous two weeks 
were excluded. One hundred patients suffering from CF, 
aged 1 to 23 years were studied from three health centers 
in Tehran during 2011 to 2012. Demographic character-
istics and medical histories were collected from medi-
cal records. The study was approved by the local ethical 
committees. 
Sputum samples or throat swabs were taken and cultured 
on cetrimide agar, blood agar and MacConkey agar and 
the plates were incubated for 72 h at 37 °C. Regardless 
of morphology of colonies, all suspected colonies pri-
marily were screened for P. aeruginosa by a combina-
tion of tests including growth on cetrimide agar, growth 
at 42 °C, and biochemical tests such as oxidase, citrate, 
OF glucose, and arginine dihydrolase. 
Genomic DNA extraction was performed using the stan-
dard phenol-chloroform extraction method [12]. Specif-
ic primers targeting the genes oprI and oprL were used 
to amplify 249 base pair (bp) and 504 bp products [13], 
respectively (Tab.  I). Amplification of oprI and oprL 
was carried out in a total reaction volume of 20 μl con-
taining 2 μl 10x PCR buffer, 1.5 mM MgCl2, 0.2 mM 
deoxynucleotide, 0.25 mM each primer (Bioneer, Seoul, 
South Korea), 0.5 U Taq polymerase, and 10 ng DNA. 
The Thermocycler (Peqlab, Germany) was set with the 
following conditions: Initial denaturation for 5 min at 
95 °C and 30 cycles consisted of denaturation for 30s 
at 95°C, annealing for 30s at 57 °C, extension for 1 min 
at 72 °C, and final extension for 10 min at 72 °C. Elec-
trophoresis was performed in a 1.5% agarose gel along 
with GeneRuler 100 bp DNA Ladder (Fermentas, Lithu-
ania) and was stained with 0.5 μg/ml ethidium bromide. 
Pseudomonas aeruginosa ATCC 27853 was used as a 
positive control in all experiments. 
Statistical analysis
The descriptive analysis was performed to calculate the 
frequency and percentage of variable using SPSS ver-
sion 11.5. 
Results
Among 100 patients with CF, 54 were females and 46 
were males. Forty two patients were younger than 7 
years old, 38 aged 7 to 14 years, and 20 aged more than 
14 years. Demographic characteristics of CF patients in-
cluding age and gender is shown in Fig. 1. 
Based on phenotypic tests, P. aeruginosa isolates were 
recovered from 40% of CF patients. The distribution of 
CF patients colonized with P. aeruginosa in relation to 
demographic characteristics is shown in Fig. 2. P. aeru-
ginosa were recovered from females (n = 19, 47.5%) and 
males (n = 21, 52.5%) in approximately similar frequen-
cy and no statistically significant difference was found. 
The colonization rate by P. aeruginosa among various 
age groups was different. An increasing trend of P. ae-
ruginosa colonization was seen ranging from 23.8% in 
the 1-7 years age group to 36.8% in the 7-14 years age 
group, and 80% in cases older than 14 years. 
For each isolate, the distinct morphotypes either mucoid 
or non-mucoied colonies grown on cetrimide agar were 
primarily identified as P. aeruginosa which oxidase- and 
citrate-positive but were OF glucose nonfermenter. Sub-
sequently, all morphotypes were distinguished from oth-
Tab. I. Specific primers sequences targeting oprI and oprL. 
Amplicon size
(bp)
Primer sequence (5′-3′) Target region
249 5′- ATgAACAACgTTCTgAAATTCTCT -3′
5′- CTTgCggCTggCTTTTTCCAg -3′
oprI
504 5′- ATggAAATgCTgAAATTCggC -3′
5′- CTTCTTCAgCTCgACgCgACg -3′
oprL
Fig. 1. distribution of patients with cystic fibrosis in relation of 
age and gender.
Fig. 2. distribution of p. aeruginosa colonized patients suffering 
from cystic fibrosis in relation of age and gender.
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er members of fluorescent pseudomonads by growth at 
42 °C. Among 40 isolates of P. aeruginosa, 19 (47.5%) 
and 17 (42.5%) were mucoid and non-mucoid, respec-
tively. In remaining isolates (n = 4, 10%) both mucoid 
and non-mucoid colonies were observed. Four (10%) 
and 17 (42.5%) isolates were arginine dihydrolase nega-
tive and non-pigmented, respectively. According to the 
combination of phenotypic and biochemical tests, 40 CF 
isolates were identified as P. aeruginosa and were con-
sidered for further identification via PCR-based assays. 
Forty isolates yielded 249 bp (Fig. 3) amplicon through 
amplification of oprI gene using genus specific primers 
confirming the identity of fluorescent pseudomonads. 
However, 37 of 40 isolates yielded 573 bp (Fig. 4) am-
plicon through amplification of oprL gene using species 
specific primers, verifying the identity of P. aeruginosa. 
Three isolates were identified as P. aeruginosa by phe-
notypic tests but did not confirmed via species specific 
PCR.
Disscusion
P. aeruginosa is not a fastidious organism and the iden-
tification of clinical isolates of P. aeruginosa is usually 
based on phenotypic methods. The phenotypic tests in-
cluding macroscopic characteristics and biochemical 
tests are the most reliable tests for identification of typi-
cal isolates of P. aeruginosa [14]. However, extensive 
alterations in phenotype of P.  aeruginosa may occur 
during chronic infection. For instance, the microenvi-
ronment of the CF lung may provide suitable conditions 
for mutation and selection of unique population of colo-
nized bacteria [15]. Conversion to mucoid and non-pig-
mented colonies is common in P. aeruginosa recovered 
from CF patients. On the other hand, CF lungs may be 
colonized with other non-fermentative Gram-negative 
bacilli which are not easily differentiated from P. ae-
ruginosa. These limitations may result in misidentifica-
tion of P. aeruginosa as the most frequent pathogen in 
CF respiratory samples  [16]. Inaccurate identification 
may affect the antibiotic susceptibility testing, admin-
istration of effective antipseudomonal antibiotics, and 
patient care. In the current study, we identified some 
of isolates with atypical phenotype; the isolates which 
non-pigmented and some isolates display a negative re-
action for arginine dihydrolase. A possible explanation 
for these findings might be the plasticity and adapta-
tion of P. aeruginosa in response to the unusual envi-
ronment in CF lungs during chronic infection. As the 
isolates of P. aeruginosa with atypical phenotype were 
observed, we considered both mucoid and non-mucoid 
as well as pigmented and non-pigmented colonies for 
molecular identification. In this study, we determined 
the identity of multiple morphotypes of P. aeruginosa 
recovered from Iranian patients suffering from CF based 
on PCR assasys. To minimize the potential error of 
single-target assays, we used two targets for molecular 
identification of P. aeruginosa. We used PCR targeting 
two genes; oprI and oprL which are peptidoglycan as-
sociated outer membrane lipoproteins. oprI gene was 
previously identified as a conserved gene in members 
of fluorescent pseudomonads and in Pseudomonadace-
ae family. As reported previously, oprI gene sequence 
is highly conserved in P. aeruginosa isolates [18]. We 
found that amplicon of oprI gene were detected in all the 
phenotypically identified isolates including mucoid and 
non-pigmented Pseudomonas. This finding indicates 
that all isolates are more likely a member of fluorescent 
pseudomonads or Pseudomonas genus. These results are 
consistent with previous studies that applied oprI gene 
for identification of Pseudomonas genus [13, 19]. More-
over, we identified the P. aeruginosa at the species level 
using oprL gene specific primers. Our findings indicate 
Fig. 3. The oprI gene amplification using specific primers yielded 
a product of 249 bp typical to Speudomonas genus. L: 100 bp lad-
der (Fermentas, Lithuania); p: positive control; 1-3: pseudomonas 
isolates of CF patients; N: Negative control (distilled water).
Fig. 4. The oprI gene amplification using specific primers yielded 
a product of 504bp typical to p. aeruginosa. L: 100 bp ladder (Fer-
mentas, Lithuania); p: positive control; 1-7: p. aeruginosa isolates 
of CF patients; N: Negative control (distilled water).
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that the majority of isolates were P. aeruginosa and three 
isolates belonged to Pseudomonas genus as amplified 
only through genus-specific primers and these isolates 
were misidentified via phenotypic methods. This study 
also demonstrated that non-aeruginosa species may iso-
lated from CF patients. The discrepancy between the 
results of phenotypic assays and molecular tests was 
not statistically significant, but species-specific PCR is 
more reliable and sensitive method for identification of 
morphotypes of P. aeruginosa. 
This study showed that the species specific PCR target-
ing oprL gene can be used as accurate test for identifica-
tion of highly adaptable P. aeruginosa in CF patients. 
This procedure may provide a simple and reliable meth-
od for identification of various morphotypes which mis-
identified via phenotypic methods. 
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